BRCA penetrance for breast and ovarian cancers:: a heterogeneity study

被引：0
|
作者：
Hassid, S.
Nogues, C.
Carayol, J.
Alarcon, F.
Mohamdi, A.
Labbe, M.
Rezvani, A.
Stoppa-Lyonnet, D.
Berthet, P.
Fricker, J. P.
Andrieu, N.
Bonaiti-Pellie, C.
机构：
[1] Inst Curie, INSERM, U794, Dept Biostat, F-75231 Paris, France
[2] INSERM, U535, F-75654 Paris 13, France
[3] Inst Curie, F-75231 Paris, France
来源：
GENETIC EPIDEMIOLOGY | 2007年 / 31卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：474 / 474
页数：1
相关论文
共 50 条
  • [1] The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers
    Paul, Arindam
    Paul, Soumen
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2014, 19 : 605 - 618
  • [2] Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families
    de Bock, G.
    van der Kolk, D.
    Schaapveld, M.
    Jansen, L.
    Mourits, M. J.
    Oosterwijk, J. C.
    EJC SUPPLEMENTS, 2010, 8 (03): : 224 - 224
  • [3] Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
    Ford, D
    Easton, DF
    Stratton, M
    Narod, S
    Goldgar, D
    Devilee, P
    Bishop, DT
    Weber, B
    Lenoir, G
    Chang-Claude, J
    Sobol, H
    Teare, MD
    Struewing, J
    Arason, A
    Scherneck, S
    Peto, J
    Rebbeck, TR
    Tonin, P
    Neuhausen, S
    Barkardottir, R
    Eyfjord, J
    Lynch, H
    Ponder, BAJ
    Gayther, SA
    Birch, JM
    Lindblom, A
    Stoppa-Lyonnet, D
    Bignon, Y
    Borg, A
    Hamann, U
    Haites, N
    Scott, RJ
    Maugard, CM
    Vasen, H
    AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (03) : 676 - 689
  • [4] PARP inhibition in BRCA-mutated breast and ovarian cancers
    Chan, Stephen L.
    Mok, Tony
    LANCET, 2010, 376 (9737): : 211 - 213
  • [5] BRCA2 mutations in primary breast and ovarian cancers
    Lancaster, JM
    Wooster, R
    Mangion, J
    Phelan, CM
    Cochran, C
    Gumbs, C
    Seal, S
    Barfoot, R
    Collins, N
    Bignell, G
    Patel, S
    Hamoudi, R
    Larsson, C
    Wiseman, RW
    Berchuck, A
    Iglehart, JD
    Marks, JR
    Ashworth, A
    Stratton, MR
    Futreal, PA
    NATURE GENETICS, 1996, 13 (02) : 238 - 240
  • [6] Heterogeneity of drug resistance in human breast and ovarian cancers
    Kern, DH
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1998, 4 (01): : 41 - 45
  • [7] Transcriptome Patterns of BRCA1- and BRCA2- Mutated Breast and Ovarian Cancers
    Arakelyan, Arsen
    Melkonyan, Ani
    Hakobyan, Siras
    Boyarskih, Uljana
    Simonyan, Arman
    Nersisyan, Lilit
    Nikoghosyan, Maria
    Filipenko, Maxim
    Binder, Hans
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (03) : 1 - 18
  • [8] The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers
    Friedenson, Bernard
    BMC CANCER, 2007, 7
  • [9] PENETRANCE OF BREAST AND OVARIAN CANCERS IN BRCA 1/2 MUTATION CARRIERS IN KOREA: USING PROBAND'S PHENOTYPE EXCLUSION LIKELIHOOD(PEL) METHOD.
    Park, C. A. Boyoung
    Kim, S. W.
    Lee, M. H.
    Lee, J. W.
    Kang, D.
    Park, S. K.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2012, 175 : S6 - S6
  • [10] The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers
    Bernard Friedenson
    BMC Cancer, 7
12345